首页> 外文OA文献 >PMD44 Economic Evaluation of the UGT1A1 Pharmacogenetic Test to inform Dose Selection of Irinotecan-Based Chemotherapy

【2h】

PMD44 Economic Evaluation of the UGT1A1 Pharmacogenetic Test to inform Dose Selection of Irinotecan-Based Chemotherapy

机译：PMD44 UGT1A1药物遗传学测试的经济评估，以告知基于伊立替康的化疗剂量选择

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Shabaruddin F.H.; Elliott R.A.; Tappenden P.; Payne K.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28 [J] . Chuan Tian, Haifeng Ying, Rongyuan Zhuang, Cancer Management and Research . 2018,第1期

机译：基于伊立替康的个体化化疗对杂合型UGT1A1 * 6或UGT1A1 * 28的晚期大肠癌的血浆SN-38水平和DPD活性的价值
2. Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28 [J] . Chuan Tian, Haifeng Ying, Rongyuan Zhuang, Cancer Management and Research . 2018,第2016期

机译：基于伊立替康的个体化化疗对杂合型UGT1A1 * 6或UGT1A1 * 28的晚期大肠癌的血浆SN-38水平和DPD活性的价值
3. Informing resource allocation decision making: economic evaluations of pharmacogenetic tests [J] . Katherine Payne, David Gurwitz Drug Development Research . 2010,第8期

机译：通知资源分配决策：药物遗传学测试的经济评估
4. A quantitative and qualitative evaluation of LISA, a decision support system for chemotherapy dosing in childhood Acute Lymphoblastic Leukaemia [C] . Jonathan Bury, Chris Hurt, Anindita Roy, MEDINFO . 2004

机译：儿童急性淋巴细胞白血病化疗计量的决策支持系统的定量和定性评价
5. Mapping Expanded Prostate Cancer Index Composite (EPIC) Questionnaire to EuroQoL-5D (EQ-5D) Utility Weights to Inform Economic Evaluations for Prostate Cancer [D] . Khairnar, Rahul. 2020

机译：将扩大的前列腺癌指数复合（EPIC）问卷调查问卷到EUROQOL-5D（EQ-5D）实用权重，以便为前列腺癌提供经济评估
6. Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28 [O] . Chuan Tian, Haifeng Ying, Rongyuan Zhuang, 2018

机译：基于伊立替康的个体化化疗对杂合型UGT1A1 * 6或UGT1A1 * 28晚期晚期大肠癌的血浆SN-38水平和DPD活性的价值
7. Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28 [O] . Chuan Tian, Haifeng Ying, Rongyuan Zhuang, 2018

机译：血浆SN-38水平和DPD活性在伊替康的个性化化疗中的高级结直肠癌杂合型UGT1A1 * 6或UGT1A1 * 28

PMD44 Economic Evaluation of the UGT1A1 Pharmacogenetic Test to inform Dose Selection of Irinotecan-Based Chemotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅